Login to Your Account



Inspiration, Ipsen Try to Lock Up Hemophilia Market in $259M Deal

By Nuala Moran


Wednesday, January 27, 2010
LONDON - Inspiration Pharmaceuticals Inc. and Ipsen SA are merging their hemophilia portfolios in a deal that will see Ipsen invest $259 million to fund clinical development of the two lead products, while Inspiration handles the work. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription